Paracetamol GIGAfarm tablets

Land: Armenien

Språk: engelska

Källa: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Produktens egenskaper Produktens egenskaper (SPC)
17-12-2019

Aktiva substanser:

paracetamol

Tillgänglig från:

Arpimed LLC

ATC-kod:

N02BE01

INN (International namn):

paracetamol

Dos:

500mg

Läkemedelsform:

tablets

Enheter i paketet:

(200/20x10/) in blister

Receptbelagda typ:

OTC

Bemyndigande status:

Registered

Tillstånd datum:

2019-12-17

Produktens egenskaper

                                SUMMARY PRODUCT CHARACTERISTIC (SPC)
PARACETAMOL GIGAfarm 500 MG TABLETS TRADE NAME – PARACETAMOL GIGAfarm 500 mg tablets INTERNATIONAL NON-PROPERTY NAME – PARACETAMOL
COMPOSITION
Each tablet_ _of _PARACETAMOL GIGAfarm 500 mg _contains:
_ACTIVE INGREDIENT: _PARACETAMOL – 500 mg;
_INACTIVE _
_INGREDIENTS:_
microcrystalline
cellulose,
lactose
monohydrate,
maize
starch,
povidone,
magnesium stearate, talc purified.
CHEMICAL NAME AND CAS NUMBER
4´-Hydroxyacetanilide; 103-90-2.
PHARMACOLOGICAL GROUP AND ATC CODE
Analgesic and antipyretic; ATC code - N02BE01.
PHARMACOLOGICAL ACTION
PARACETAMOL has analgesic, antipyretic and weak inflammatory action.
The mechanism of action
is associated with inhibition of prostaglandin synthesis and the
influence on the thermoregulation
center in the hypothalamus.
PHARMACOKINETICS
PARACETAMOL is readily absorbed from the gastrointestinal tract with
peak plasma concentrations
occurring about 10 to 60 minutes after oral doses. PARACETAMOL is
distributed into most body
tissues. It crosses the placenta and is present in breast milk.
Plasma-protein binding is negligible at
usual therapeutic concentrations but increases with increasing
concentrations. The elimination half-life
of PARACETAMOL varies from about 1 to 3 hours.
PARACETAMOL is metabolised predominantly in the liver and excreted in
the urine mainly as the
glucuronide and sulfate conjugates. Less than 5% is excreted as
unchanged PARACETAMOL. A
minor hydroxylated metabolite (_N_-acetyl-_p_-benzoquinoneimine), is
usually produced in very small
amounts by cytochrome P450 isoenzymes (mainly CYP2E1 and CYP3A4) in
the liver and kidney. It is
usually detoxified by conjugation with glutathione but may accumulate
following PARACETAMOL
overdosage and cause tissue damage. USES

Pain
syndrome
of
mild
to
moderate
intensity
of
different
genesis
(including
headache,
toothache, neuralgia, myalgia, arthralgia);

Catarrhal fever and infectious and inflammatory diseases; ADMINISTRATION
The usual ADULT AND CHILDREN OVER 12 YEARS SINGLE DOSE
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel ryska 17-12-2019

Sök varningar relaterade till denna produkt